BioCatalyst

PA5108 Ocular Implant low dose, PA5108 Ocular Implant, high dose, Latanoprost 0.005% Ophthalmic Solution — catalyst calendar

1 verified catalyst event(s) referencing PA5108 Ocular Implant low dose, PA5108 Ocular Implant, high dose, Latanoprost 0.005% Ophthalmic Solution, each linked to its official source. Verified as of 2026-08-06.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-11-15
in 3mo
ESTIMATED
 READOUT
Evaluate Efficacy and Safety of PA5108 Ocular Implants in Primary Open Angle Gla
Phase 2 · Glaucoma, Open-Angle, Ocular Hypertension
 PolyActiva Pty Ltd PA5108 Ocular Implant low dose, PA5108 O ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.